menu
    • menu

    Company profile for Kyowa Kirin

    NEW Drugs in Dev: 59
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.We are opening up the path toward the development of new biologics, and developing new medicines to meet medical needs that are currently not ...
    Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.We are opening up the path toward the development of new biologics, and developing new medicines to meet medical needs that are currently not being satisfied by existing pharmaceuticals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kyowa Kirinjapan Flag
    Country
    Country
    Japan
    Address
    Address
    Ohtemachi Building, 1-6-1 Ohtemachi,
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.kyowa-kirin.com
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Asia Pharma Expo

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia
    OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia

    06 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/amgen-kyowa-ox40-divorce-roche-rnai-deal-daiichi-adc-cull

    FIERCE PHARMA
    06 Feb 2026
    Share Share
    Amgen Terminates Autoimmune Partnership With Kyowa Kirin
    Amgen Terminates Autoimmune Partnership With Kyowa Kirin

    02 Feb 2026

    // BIOSPACE

    https://www.biospace.com/business/amgen-ends-autoimmune-alliance-with-kyowa-kirin-amid-safety-efficacy-questions

    BIOSPACE
    02 Feb 2026
    Share Share
    Amgen Exits $400M Autoimmune Pact After Running Vast Program
    Amgen Exits $400M Autoimmune Pact After Running Vast Program

    30 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/amgen-jilts-kyowa-exiting-400m-autoimmune-pact-after-running-vast-pivotal-program

    FIERCE BIOTECH
    30 Jan 2026
    Share Share
    Kyowa Kirin To Resume Rocatinlimab Program For Atopic Dermatitis
    Kyowa Kirin To Resume Rocatinlimab Program For Atopic Dermatitis

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229497/0/en/Kyowa-Kirin-to-Regain-Control-of-Rocatinlimab-Development-and-Commercialization-Program-Demonstrating-Strong-Commitment-to-Address-High-Unmet-Medical-Need-in-Atopic-Dermatitis.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    Biocon Biologics Gets Global Rights For Biosimilar Adalimumab
    Biocon Biologics Gets Global Rights For Biosimilar Adalimumab

    23 Dec 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-biologics-gets-global-rights-for-biosimilar-adalimumab/articleshow/126140085.cms

    ECONOMICTIMES
    23 Dec 2025
    Share Share
    Kyowa Kirin Poised For Windfall With Newborn Screening Update
    Kyowa Kirin Poised For Windfall With Newborn Screening Update

    19 Dec 2025

    // BIOSPACE

    https://www.biospace.com/business/kyowa-kirin-could-get-windfall-from-updated-newborn-screening-recommendations

    BIOSPACE
    19 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Kyowa Kirin and get a quotation

    Kyowa Kirin is a supplier offers 7 products (APIs, Excipients or Intermediates).

    Find a price of 7-Hydroxystaurosporine bulk offered by Kyowa Kirin

    Find a price of Istradefylline bulk offered by Kyowa Kirin

    Find a price of Olopatadine Hydrochloride bulk offered by Kyowa Kirin

    Find a price of RGI-2001 bulk offered by Kyowa Kirin

    Find a price of Spicamycin Analog bulk offered by Kyowa Kirin

    Find a price of ASKP1240 MONOCLONAL ANTIBODY DRUG SUBSTANCE AND DRUG PRODUCT bulk offered by Kyowa Kirin

    Find a price of KW-6356 DRUG SUBSTANCE bulk offered by Kyowa Kirin

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search